A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
PMID:
38324483
Año de publicación:
2024
Autores:
Harrison Stephen A, Bedossa Pierre, Guy Cynthia D, Schattenberg Jörn M, Loomba Rohit, Taub Rebecca, Labriola Dominic, Moussa Sam E, Neff Guy W, Rinella Mary E, Anstee Quentin M, Abdelmalek Manal F, Younossi Zobair, Baum Seth J, Francque Sven, Charlton Michael R, Newsome Philip N, Lanthier Nicolas, Schiefke Ingolf, Mangia Alessandra, Pericàs Juan M, Patil Rashmee, Sanyal Arun J, Noureddin Mazen, Bansal Meena B, Alkhouri Naim, Castera Laurent, Rudraraju Madhavi, Ratziu Vlad, MAESTRO-NASH Investigators
Revista:
The New England journal of medicine